Search results
2 days ago · 10 Wall Street research analysts have issued twelve-month price objectives for Vertex's shares. Their VERX share price targets range from $29.00 to $45.00. On average, they anticipate the company's stock price to reach $35.67 in the next year. This suggests a possible upside of 5.8% from the stock's current price.
4 days ago · Vertex Pharmaceuticals last announced its quarterly earnings results on May 6th, 2024. The pharmaceutical company reported $4.76 earnings per share for the quarter, topping the consensus estimate of $3.66 by $1.10. The business had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.58 billion.
5 days ago · Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and ...
4 days ago · A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
4 days ago · Based in Massachusetts and incorporated in 1989, Vertex Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and ...
20 hours ago · Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $455.20, which is a -0.38% downside from current levels. In a report released on May 24, Bank of ...
